Skip to main content
Livermore
Livermore
ZHEN

Van Eck Associates Corp

SEC CIK
0000869178
Latest filing
Aug 14, 2026

GILD holding history

Gilead Sciences, Inc. in every 13F filed by Van Eck Associates Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GILD overviewAll 13F holders of GILDFull Q2 2026 holdings

Shares (Q2 2026)
716,459
Value
$90.5M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of GILD by Van Eck Associates Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026716,459$90.5M0.1%−488,138−40.5%ReducedHolders
Q1 20261,204,597$167.9M0.1%−55,049−4.4%ReducedHolders
Q4 20251,259,646$154.6M0.1%+6240.0%AddedHolders
Q3 20251,259,022$139.8M0.1%−4,961−0.4%ReducedHolders
Q2 20251,263,983$140.1M0.2%−2,131,792−62.8%ReducedHolders
Q1 20253,395,775$380.5M0.5%−2,727,494−44.5%ReducedHolders
Q4 20246,123,269$565.6M0.7%−219,562−3.5%ReducedHolders
Q3 20246,342,831$553.3M0.7%+22,847+0.4%AddedHolders
Q2 20246,319,984$433.6M0.6%+747,831+13.4%AddedHolders
Q1 20245,572,153$408.2M0.6%+579,738+11.6%AddedHolders
Q4 20234,992,415$404.4M0.7%+457,576+10.1%AddedHolders
Q3 20234,534,839$339.8M0.7%+702,342+18.3%AddedHolders
Q2 20233,832,497$295.4M0.6%+1,832,292+91.6%AddedHolders
Q1 20232,000,205$166.0M0.4%+18,287+0.9%AddedHolders
Q4 20221,981,918$170.1M0.4%−1,681,089−45.9%ReducedHolders
Q3 20223,663,007$226.0M0.7%−206,643−5.3%ReducedHolders
Q2 20223,869,650$239.2M0.6%+311,736+8.8%AddedHolders
Q1 20223,557,914$211.5M0.4%+236,611+7.1%AddedHolders
Q4 20213,321,303$241.2M0.6%+149,594+4.7%AddedHolders
Q3 20213,171,709$221.5M0.6%+208,266+7.0%AddedHolders
Q2 20212,963,443$204.1M0.5%+403,756+15.8%AddedHolders
Q1 20212,559,687$165.4M0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.